TapewireFind a company

person · Reporting owner

Smith Michael Alexander

Disclosed activity across 1 company

Tapewire entity
35782
SEC CIK
0001870278

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
INSMED IncINSM · Entity 3174Chief Legal OfficerJune 22, 2026June 24, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

INSMED Inc

Report date June 22, 2026 · Filed June 24, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect37,648 Reported balance After 2026-06-22 transaction · row 1
1 source row

Row 1 · 2026-06-22 · Sale · Disposed 1,806 · Balance 37,648

F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 10, 2025 Filed Jan 10, 2025 23:44 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 319 $63.38 $20,218.22
Disclosure

SEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 4

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,965

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 23:44 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 27,370 $0.00 Strike: $65.72 $0.00
Disclosure

SEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · derivative · entry 5

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,370

Underlying: Common Stock · 27,370 shares

Expires 2035-01-08

F6 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 23:44 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 5,706 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 3

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,284

F4 · shares: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

F5 · price: Each RSU was granted on January 8, 2025 for no consideration.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 23:44 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 1,064 $66.21 $70,447.44
Disclosure

SEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,578

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:44 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 2,306 $65.98 $152,149.88
Disclosure

SEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,642

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 2,306 shares sold at prices ranging from $65.96 to $66.04 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F3 · balance_after: Includes 92 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 20:47 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 7,000 $0.00 Strike: $22.76 $0.00
Disclosure

SEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · derivative · entry 4

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,000 shares

Expires 2025-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 20:47 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 9,000 $74.75 $672,750.00
Disclosure

SEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · nonDerivative · entry 3

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,856

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 9,000 shares sold at prices ranging from $74.61 to $74.90 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 20:47 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 18,871 $74.16 $1,399,473.36
Disclosure

SEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,856

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 18,871 shares sold at prices ranging from $73.61 to $74.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 20:47 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 7,000 $22.76 $159,320.00
Disclosure

SEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,727

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
August 12, 2024 Filed Aug 14, 2024 20:28 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 34,530 $0.00 Strike: $17.07 $0.00
Disclosure

SEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · derivative · entry 8

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,530

Underlying: Common Stock · 34,530 shares

Expires 2032-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the date of grant.

Read SEC document
August 12, 2024 Filed Aug 14, 2024 20:28 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 41,640 $0.00 Strike: $13.91 $0.00
Disclosure

SEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · derivative · entry 7

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 41,640 shares

Expires 2029-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
August 12, 2024 Filed Aug 14, 2024 20:28 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 11,900 $0.00 Strike: $17.16 $0.00
Disclosure

SEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · derivative · entry 6

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,900 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
August 12, 2024 Filed Aug 14, 2024 20:28 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 20,415 $73.65 $1,503,564.75
Disclosure

SEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · nonDerivative · entry 5

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,727

F2 · price: This is the weighted average sales price representing 20,415 shares sold at prices ranging from $73.22 to $74.11 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
August 12, 2024 Filed Aug 14, 2024 20:28 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 67,655 $72.75 $4,921,901.25
Disclosure

SEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · nonDerivative · entry 4

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,142

F1 · price: This is the weighted average sales price representing 67,655 shares sold at prices ranging from $72.22 to $73.22 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
August 12, 2024 Filed Aug 14, 2024 20:28 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 34,530 $17.07 $589,427.10
Disclosure

SEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · nonDerivative · entry 3

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,797

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2024 Filed Aug 14, 2024 20:28 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 41,640 $13.91 $579,212.40
Disclosure

SEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,267

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2024 Filed Aug 14, 2024 20:28 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 11,900 $17.16 $204,204.00
Disclosure

SEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,627

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 08, 2024 Filed Jul 10, 2024 21:19 UTC INSMED Inc INSM · Entity 3174 Tax withholdingCommon Stock 730 $70.05 $51,136.50
Disclosure

SEC source: 0001628280-24-031618 · wk-form4_1720646371.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,727

F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of Restricted Stock Units ("RSUs").

F2 · price: Represents the closing price of Common Stock on the vesting date of the RSUs.

F3 · balance_after: Includes 629 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 14,810 $0.00 Strike: $13.67 $0.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 11

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,810 shares

Expires 2027-01-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 3,470 $0.00 Strike: $11.38 $0.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 10

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,470 shares

Expires 2026-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 3,691 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 9

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,691 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $16.16 $0.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 8

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2026-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 7,000 $0.00 Strike: $16.07 $0.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 7

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,000 shares

Expires 2025-01-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 44,722 $49.53 $2,215,080.66
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 6

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,828

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 14,810 $13.67 $202,452.70
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 5

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 3,470 $11.38 $39,488.60
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 4

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 3,691 $10.85 $40,047.35
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 3

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,270

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 10,000 $16.16 $161,600.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,579

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:45 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 7,000 $16.07 $112,490.00
Disclosure

SEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 101,579

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 14, 2024 Filed May 15, 2024 20:37 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 5,093 $25.40 $129,362.20
Disclosure

SEC source: 0001628280-24-023608 · wk-form4_1715805452.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,579

F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.

F4 · price: This is the weighted average sales price representing 5,093 shares sold at prices ranging from $25.38 to $25.42 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 13, 2024 Filed May 15, 2024 20:37 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 65,230 $0.00 Strike: $25.83 $0.00
Disclosure

SEC source: 0001628280-24-023608 · wk-form4_1715805452.xml · derivative · entry 3

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,230

Underlying: Common Stock · 65,230 shares

Expires 2034-05-13

F5 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the Initial Vesting Date.

Read SEC document
May 13, 2024 Filed May 15, 2024 20:37 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 13,308 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-023608 · wk-form4_1715805452.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,672

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% percent on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

F2 · price: Each RSU was granted on May 13, 2024 for no consideration.

Read SEC document
January 09, 2024 Filed Jan 11, 2024 21:11 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 2,373 $28.76 $68,247.48
Disclosure

SEC source: 0001628280-24-001165 · wk-form4_1705007495.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,364

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 2,373 shares sold at prices ranging from $28.75 to $28.79 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 05, 2024 Filed Jan 5, 2024 22:32 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 627 $29.31 $18,374.24
Disclosure

SEC source: 0001628280-24-000697 · wk-form4_1704493968.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,737

F4 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
January 04, 2024 Filed Jan 5, 2024 22:32 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 58,260 $0.00 Strike: $29.13 $0.00
Disclosure

SEC source: 0001628280-24-000697 · wk-form4_1704493968.xml · derivative · entry 3

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,260

Underlying: Common Stock · 58,260 shares

Expires 2034-01-04

F5 · derivative.exercise_date: Stock options granted under the Company's Amended and Restated 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.

Read SEC document
January 04, 2024 Filed Jan 5, 2024 22:32 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 11,800 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-000697 · wk-form4_1704493968.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,364

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration.

F3 · balance_after: Includes 422 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:01 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 740 $20.18 $14,933.20
Disclosure

SEC source: 0001140361-23-034422 · form4.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,142

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · balance_after: Includes 800 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
May 17, 2023 Filed May 17, 2023 20:14 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 1,263 $18.18 $22,961.34
Disclosure

SEC source: 0001628280-23-018696 · wf-form4_168435443742523.xml · nonDerivative · entry 3

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,082

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
May 16, 2023 Filed May 17, 2023 20:14 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 475 $18.43 $8,754.25
Disclosure

SEC source: 0001628280-23-018696 · wf-form4_168435443742523.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,345

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F3 · price: This is the weighted average sales price representing 475 shares sold at prices ranging from $18.40 to $18.45 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:14 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 1,897 $19.24 $36,498.28
Disclosure

SEC source: 0001628280-23-018696 · wf-form4_168435443742523.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,820

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 1,897 shares sold at prices ranging from $19.24 to $19.26 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:14 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 121,850 $0.00 Strike: $18.95 $0.00
Disclosure

SEC source: 0001628280-23-018180 · wf-form4_168418166701360.xml · derivative · entry 2

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,850

Underlying: Common Stock · 121,850 shares

Expires 2033-05-11

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:14 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 26,385 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018180 · wf-form4_168418166701360.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,717

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration.

Read SEC document
January 10, 2023 Filed Jan 12, 2023 21:13 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 1,836 $17.93 $32,919.48
Disclosure

SEC source: 0001628280-23-000962 · wf-form4_167355796596777.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,332

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 1,836 shares sold at prices ranging from $17.92 to $17.96 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:29 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 29,050 $0.00 Strike: $19.74 $0.00
Disclosure

SEC source: 0001870278-23-000001 · wf-form4_167304054671097.xml · derivative · entry 3

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,050

Underlying: Common Stock · 29,050 shares

Expires 2033-01-05

F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:29 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 6,332 Not disclosed Not disclosed
Disclosure

SEC source: 0001870278-23-000001 · wf-form4_167304054671097.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,168

F3 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.

F4 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:29 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 720 $19.72 $14,198.40
Disclosure

SEC source: 0001870278-23-000001 · wf-form4_167304054671097.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,836

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · balance_after: Includes 101 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
July 12, 2022 Filed Jul 12, 2022 20:06 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 941 $23.40 $22,019.40
Disclosure

SEC source: 0001870278-22-000001 · wf-form4_165765636118954.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,455

F1 · shares: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

F2 · balance_after: Includes 813 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
May 17, 2022 Filed May 18, 2022 20:07 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 1,055 $20.37 $21,490.35
Disclosure

SEC source: 0001140361-22-019785 · form4.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,583

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing the shares sold at prices ranging from $20.33 to $20.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 16, 2022 Filed May 18, 2022 20:07 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 433 $18.48 $8,001.84
Disclosure

SEC source: 0001140361-22-019785 · form4.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,638

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

Read SEC document
May 11, 2022 Filed May 13, 2022 22:13 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 69,060 $0.00 Strike: $17.07 $0.00
Disclosure

SEC source: 0001140361-22-019175 · form4.xml · derivative · entry 2

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,060

Underlying: Common Stock · 69,060 shares

Expires 2032-05-11

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.